Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. (BLCM) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BLCM · as of Jun 30, 2023
Ownership Breakdown
4
Institutional Holders
▼ 18 vs Q1
$173,482
Total Inst. Value
▼ $296,933 vs Q1
10.41M
Shares Outstanding
freeFloat 65.08%
467,520
13F Shares Held
▼ 955,625 vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BLCM largest shareholders · institutional ownership
Q2 2023 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BOXER CAPITAL, LLC pharmaceutical preparations | 450.0K | 1.46% | 1.46% | $167.00M | Aug 14, 2023 | ▲ 450.0K |
B. RILEY WEALTH ADVISORS, INC. pharmaceutical preparations | 11.4K | 3.70% | 3.70% | $4.22M | Jul 27, 2023 | NEW |
TEKLA CAPITAL MANAGEMENT LLC pharmaceutical preparations | 6.0K | 1.95% | 1.95% | $2.22M | Aug 10, 2023 | — held |
PRINCETON GLOBAL ASSET MANAGEMENT LLC pharmaceutical preparations | 100 | 0.03% | 0.03% | $37,000 | Aug 4, 2023 | — held |
GROUP ONE TRADING, L.P. pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 9, 2023 | EXIT |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 11, 2023 | EXIT |
STATE STREET CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 14, 2023 | EXIT |
MORGAN STANLEY pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 14, 2023 | EXIT |
BAKER BROS. ADVISORS LP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 14, 2023 | EXIT |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 11, 2023 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2023 vs prior quarter
Q2 2023
1
Increased
+450.0K shares1
New Positions
first time holders0
Decreased
−0 shares20
Sold Out
fully exitedNet shares change (top 50)
+450.0K
+450.0K / −0
Net new holders
-18
1 new / 20 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BLCM insider trading · insider activity
Source: SEC Form 4
2
Buy transactions
2
Sell transactions
1.00
Buy/Sell ratio
$2M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
BAKER BROS. ADVISORS LP 10 percent owner | Nov 22, 2023 | X-InTheMoney | 1,941,607 | $0.00 | $194.161 | 14.22M | Form 4 ↗ |
BAKER BROS. ADVISORS LP 10 percent owner | Nov 22, 2023 | X-InTheMoney | 1,941,607 | $0.00 | $194.161 | 2.17M | Form 4 ↗ |
BAKER BROS. ADVISORS LP 10 percent owner | Nov 22, 2023 | X-InTheMoney | 174,742 | $0.00 | $17.474 | 1.29M | Form 4 ↗ |
BAKER BROS. ADVISORS LP 10 percent owner | Nov 22, 2023 | X-InTheMoney | 174,742 | $0.00 | $17.474 | 196.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Bellicum Pharmaceuticals, Inc. (BLCM) is primarily owned by institutional investors, who hold approximately 4.5% of total shares outstanding. Company insiders own approximately 34.92%, while retail and public investors account for the remaining 60.59%.
The largest institutional shareholder of Bellicum Pharmaceuticals, Inc. is BOXER CAPITAL, LLC, holding approximately 450,000 shares — equal to 1.46% of outstanding shares — as of June 30, 2023.
A total of 4 institutional investors currently hold BLCM stock, with a combined institutional value of approximately $173,482 as of the most recent 13F filing period.
Frequently asked questions
BLCM ownershipBellicum Pharmaceuticals, Inc. (BLCM) is primarily owned by institutional investors, who hold approximately 4.5% of shares. The largest shareholder is BOXER CAPITAL, LLC with a 1.46% stake. Company insiders hold 34.92%. Data sourced from SEC Form 13F as of June 30, 2023.